Showing results (561-570 of 5,340) with videos related to

Sort By:
Pageof 534
Japanese Journal of Clinical Oncology|October 7, 2004
The novel germline mutation of the hMLH1 gene in a case of suspected hereditary non-polyposis colorectal cancer (HNPCC) in a patient with no family history of cancerNaohiro Tomita, Mutsumi Fukunaga, Shu Okamura, et al.
Japanese Journal of Clinical Oncology|September 3, 2004
Clinical trials for malignant lymphoma in JapanKensei Tobinai, Tomomitsu Hotta
Japanese Journal of Clinical Oncology|May 4, 2004
15-year experience on intravesical therapy of T1G3 urinary bladder cancer: a conservative approachChi Wai Cheng, Siu Foon Peter Chan, Lung Wai Chan, et al.
Japanese Journal of Clinical Oncology|June 18, 2005
Psychiatric disorders following first breast cancer recurrence: prevalence, associated factors and relationship to quality of lifeMasako Okamura, Shigeto Yamawaki, Tatsuo Akechi, et al.
Japanese Journal of Clinical Oncology|May 12, 2005
The usefulness of MRI and PET imaging for the detection of parametrial involvement and lymph node metastasis in patients with cervical cancerWon Park, Young Je Park, Seung Jae Huh, et al.
Japanese Journal of Clinical Oncology|May 12, 2005
CD10-positive stromal cells in gastric carcinoma: correlation with invasion and metastasisWen-Bin Huang, Xiao-Jun Zhou, Jie-Yu Chen, et al.
Japanese Journal of Clinical Oncology|February 15, 2005
Radiation therapy for adrenal gland metastases from hepatocellular carcinomaZhao-Chong Zeng, Zhao-You Tang, Jia Fan, et al.
Japanese Journal of Clinical Oncology|February 15, 2005
Induced oxidative stress and decreased expression of inducible heat shock protein 70 (ihsp 70) in patients with colorectal adenocarcinomasGül Ozdemirler Erata, Oznur Kanbağli, Ozgür Durlanik, et al.
Japanese Journal of Clinical Oncology|March 8, 2006
Cyclin E expression in operable breast cancer quantified using real-time RT-PCR: a comparative study with immunostainingPiotr Potemski, Elzbieta Pluciennik, Andrzej K Bednarek, et al.
Japanese Journal of Clinical Oncology|January 24, 2008
A phase I study of combination therapy of the oral fluorinated pyrimidine compound S-1 with low-dose cisplatin twice-a-week administration (JFMC27-9902 Step2) in patients with advanced gastric cancer using a continual reassessment methodSatoshi Morita, Bunzo Nakata, Akihito Tsuji, et al.
Pageof 534